we have developed a way to study whether these hemopoietic effects become long-term consequences of cancer , using llc-bearing mice with advanced tumor treated with the antineoplastic agent tiazofurin , 2-beta-d-ribofuranosyl-thiazole-4-carboxyamide , nsc 286193 ( tz ) .
C0006826
cancer
C0027651
tumor